story of the week
Bleeding Risk Associated With Combination Intrapleural Fibrinolytic and Enzyme Therapy for Pleural Infection
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Chest
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Bleeding risk with combination intrapleural fibrinolytic and enzyme therapy in pleural infection - an international, multicenter, retrospective cohort study
Chest 2022 Jun 15;[EPub Ahead of Print], J Akulian, EO Bedawi, H Abbas, C Argento, DT Arnold, A Balwan, H Batra, JP Uribe Becerra, A Belanger, K Berger, AC Burks, J Chang, AA Chrissian, DM DiBardino, XF Fuentes, YB Gesthalter, CR Gilbert, K Glisinski, M Godfrey, JA Gorden, H Grosu, M Gupta, F Kheir, KC Ma, A Majid, F Maldonado, NA Maskell, H Mehta, J Mercer, J Mullon, D Nelson, E Nguyen, EM Pickering, J Puchalski, C Reddy, AE Revelo, L Roller, A Sachdeva, T Sanchez, P Sathyanarayan, R Semaan, M Senitko, S Shojaee, R Story, J Thiboutot, M Wahidi, CL Wilshire, D Yu, A Zouk, NM Rahman, L YarmusFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.